mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.007 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.008 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.01 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.02 |